Both mobilization of CD34 + HSPCs from BM and their angiogenic function are impaired in patients with DM, a condition often referred to as ‘mobilopathy’ at least in part associated with the deregulation of ncRNAs [10, 70, 73–76]. The gene discussed is CD34; the disease is diabetes mellitus.